Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Large Cohort Study of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas

NCT05433935 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT05433935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05433935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Large Cohort Study of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Lead sponsor
Zhejiang University
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2022
Completion date
December 31, 2033
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraductal papillary mucinous neoplasm